FBInvestor
Stocks / Abeona Therapeutics Inc
Institutional Ownership

Abeona Therapeutics Inc

CUSIP 00289Y206COM NEWABEOQ1 2026

13D / 13G Filings
34
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
15.3%
Max % of class reported
Institutional Holders
102
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

34 filings · latest Feb 12, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 12, 2026Adage Capital Management, L.P.13G/A49SEC
2Nov 13, 2025Adage Capital Management, L.P.13G/A10.0%5.35MSEC
3Oct 30, 2025The Vanguard Group13G5.1%2.60MSEC
4Oct 6, 2025Nantahala Capital Management, LLC13G/A10.0%5.18MSEC
5Oct 6, 2025Nantahala Capital Partners Limited Partnership13G5.1%2.62MSEC
6Sep 30, 2025James Russell Revocable Trust13G5.3%2.72MSEC
7Aug 13, 2025Suvretta Capital Management, LLC13G/A5.2%2.68MSEC
8Jul 17, 2025Blackrock, Inc.13G5.8%2.95MSEC
9May 15, 2025Nantahala Capital Management, LLC13G/A10.0%5.00MSEC
10May 12, 2025Adage Capital Management, L.P.13G/A8.8%4.41MSEC

24 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Abeona Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →